Clinical Trial Update: RCT for Gambling and Naltrexone, Using Use Eye-tracking Analysis to Predict Treatment Response [Phase 2]

View source ↗

Summary

Phase 2 randomized trial examining naltrexone for gambling disorder with eye-tracking to predict treatment response; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gambling Disorder

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: University of Sao Paulo | Conditions: Eye Tracking, Gambling Disorder | Phase 2 | Status: UNKNOWN